Intuitive Surgical, Inc. (LON:0R29)

Sage Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	2,608	2,323	1,798	1,322	1,705	1,061
Depreciation & Amortization	530.8	455.7	402.2	353.8	307.4	270.8
Other Amortization	37.9	37.7	33	26.6	22	17.1
Loss (Gain) From Sale of Assets	5.2	5.2	19.6	8.2	2.8	5.4
Loss (Gain) From Sale of Investments	-44.8	-43.3	7.3	49	10.6	-55.1
Stock-Based Compensation	731.3	676.8	592.8	513.2	449.2	395.4
Other Operating Activities	-106	-120.4	-261.5	-163.2	-39.1	63.8
Change in Accounts Receivable	-161	-95.9	-186.3	-159.3	-142.3	5.7
Change in Inventory	-934.8	-830	-712.5	-546.6	-256	-170.1
Change in Accounts Payable	73.6	-0.4	41.7	21.3	36	-32.3
Change in Unearned Revenue	94.3	31.2	53.4	21.5	32.6	15
Change in Other Net Operating Assets	-8	-24.2	26.1	44	-38.4	-91.5
Operating Cash Flow	2,826	2,415	1,814	1,491	2,089	1,485
Operating Cash Flow Growth	69.98%	33.15%	21.67%	-28.65%	40.72%	-7.09%
Capital Expenditures	-831.8	-1,111	-1,064	-532.4	-339.5	-341.5
Cash Acquisitions	-2.2	-1	-8.9	-12.8	-22.7	-37.7
Investment in Securities	-1,369	-2,161	713	1,916	-2,099	-561.4
Investing Cash Flow	-2,203	-3,273	-360.1	1,371	-2,462	-940.6
Issuance of Common Stock	361.2	429.4	296.3	233.8	276.5	308.8
Repurchase of Common Stock	-597.2	-270	-581	-2,802	-211.6	-309.5
Other Financing Activities	-	-8.5	-2.9	-4.5	-21.9	-85
Financing Cash Flow	-236	150.9	-287.6	-2,572	43	-85.7
Foreign Exchange Rate Adjustments	-7.4	-0.8	3.3	5.4	-3.4	-2.6
Net Cash Flow	379.7	-707.7	1,169	294.7	-332.5	455.9
Free Cash Flow	1,994	1,304	749.6	958.4	1,750	1,143
Free Cash Flow Growth	375.40%	73.93%	-21.79%	-45.23%	53.06%	-2.50%
Free Cash Flow Margin	21.81%	15.61%	10.52%	15.40%	30.65%	26.23%
Free Cash Flow Per Share	5.48	3.60	2.10	2.65	4.78	3.17
Cash Income Tax Paid	466.5	466.5	447.8	444.2	180	34.4
Levered Free Cash Flow	1,825	1,197	779.25	1,115	1,611	900.83
Unlevered Free Cash Flow	1,825	1,197	779.25	1,115	1,611	900.83
Change in Net Working Capital	317.2	354.5	294.2	252.6	-26.5	100.4

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.